Trials / Completed
CompletedNCT04184258
Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem Cells
Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Olfactory Mucosa Derived Mesenchymal Stem Cells
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus · Other Government
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Treatment of systemic lupus erythematosus with pooled allogenic mesenchymal stem cells
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Pooled mesenchymal stem cell | Pooled allogenic mesenchymal stem cell derived from olfactory mucosa |
| OTHER | Standard treatment according to the Clinical protocols | Standard SLE treatment according to the Clinical protocols approved by the Ministry of healthcare of Republic of Belarus |
Timeline
- Start date
- 2019-07-01
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2019-12-03
- Last updated
- 2021-01-22
Locations
1 site across 1 country: Belarus
Source: ClinicalTrials.gov record NCT04184258. Inclusion in this directory is not an endorsement.